Featured Articles: Volume 5:2
Spend a few days talking to the rheumatologists at Boston’s Brigham and
Women’s Hospital and, guaranteed, you walk away greatly impressed. There
are many words one can use to try to summarize this large rheumatology
division, but it turns out a very good one is simply this: Power.
Results from comparative effectiveness research (CER) are of growing
importance in the current health care debate. Patients, providers and
policymakers are demanding better information on whether a given
intervention not only works but also which is the “best” intervention
for a given patient.
Despite the huge amount of money
and narcotics used to treat pain, 40% of chronic pain patients do not
achieve adequate pain relief. Adjuvant nonopioid medications can reduce
both pain symptoms and opiate requirements, but fewer than 15% of
chronic pain patients use them.
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease driven by autoantibodies and an orchestra of immunologically overactive cells that primarily targets synovial joints, as well as extra-articular tissues and organs.